Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Highridge Medical is a global leader in the spinal device market, established in 2024 following the acquisition of ZimVie's spine business by H.I.G. Capital. The company integrates the extensive heritage of Biomet Spine and Zimmer Biomet's spinal divisions, providing a robust portfolio of implants and instrumentation for complex spine, minimally invasive surgery, and motion preservation. Its flagship products include the Mobi-C Cervical Disc, the first FDA-approved cervical disc for both one- and two-level applications, and The Tether, a pioneering solution for pediatric scoliosis. Highridge Medical is committed to improving patient outcomes by delivering innovative surgical solutions and comprehensive clinical support to surgeons worldwide. The company operates as a standalone entity focused exclusively on advancing the standard of care in spinal health through its diverse range of fusion and non-fusion technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomet Spine.